MicroRNA126 is downregulated in thyroid cancer cells, and regulates proliferation, migration and invasion by

Yan Qian1, Xiaoli Wang2, Zhanlu Lv1

  • 1Department of Environmental Pollution and Health, State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences, Beijing 100012, P.R. China.

Insights

MicroRNA-126 (miR-126) is downregulated in thyroid cancer, inhibiting cancer cell proliferation, migration, and invasion. This suggests miR-126 could be a potential therapeutic target for thyroid cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-126 (miR-126) is known to be downregulated in several cancers.
  • Its role in human thyroid cancer has not been previously investigated.

Purpose of the Study:

  • To determine the expression levels of miR-126 in human thyroid cancer.
  • To investigate the functional effects of miR-126 on thyroid cancer cell behavior.
  • To identify potential molecular targets of miR-126 in thyroid cancer.

Main Methods:

  • Quantitative polymerase chain reaction (qPCR) to measure miR-126 expression in tumor tissues and cell lines.
  • Cell proliferation, migration, and invasion assays.
  • Western blot analysis and luciferase assays to confirm direct targeting of C-X-C chemokine receptor type 4 (CXCR4).

Main Results:

  • miR-126 expression was significantly downregulated in thyroid cancer tissues and cell lines compared to normal controls.
  • Upregulation of miR-126 using mimics suppressed thyroid cancer cell proliferation, migration, and invasion.
  • miR-126 was found to directly target CXCR4 in thyroid cancer cells.

Conclusions:

  • miR-126 plays an inhibitory role in thyroid cancer progression.
  • The findings suggest that miR-126, by targeting CXCR4, could serve as a novel therapeutic target for thyroid cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K